The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.

The investigational agent uses 60% less gadolinium without sacrificing image quality, according to recent clinical trial findings.

According to new data, the simulated virtual environment may be just as effective of a setting as the classroom for problem-based learning. 

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Radiology advocates on Monday said they were "deeply disappointed" with the decision while emphasizing it is still early in the process. 

UPDATED: “These high numbers highlight the disconnect between the two sides as they debate what constitutes a reasonable payment for OON services,” experts write in Health Affairs. 

IR is the fastest growing specialty in California, with demand at 1.5 to 2 times the national average, according to new data from analytics firm Axuall. 

On Monday a district judge in Massachusetts declared the Trump administration’s squashing of billions in NIH grants “void and illegal.”